Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Karl

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
The American Surgeon|October 16, 2004
Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapyS T Kelley, M Bloomston, F Serafini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pumpK V Shepard, B Levin, R C Karl, et al.
The Journal of Surgical Research|February 10, 2009
Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancerMarcovalerio Melis, James M McLoughlin, E Michelle Dean, et al.
The Journal of Surgical Research|August 25, 2007
Perspectives of third-year medical students toward their surgical clerkship and a surgical careerSteven B Goldin, Monika M Wahi, Lucas R Wiegand, et al.
Journal of the American College of Surgeons|May 13, 2008
Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer?James M McLoughlin, Marcovalerio Melis, Erin M Siegel, et al.
Annals of Surgical Oncology|November 3, 2011
Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomyGeorge W Dittrick, Jill M Weber, Ravi Shridhar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1993
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304E J Anaissie, D P Kontoyiannis, S Vartivarian, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 6, 2016
Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care centerAhmed I Salem, Matthew R Thau, Tobin J Strom, et al.
Annals of Surgical Oncology|September 25, 2010
An elevated body mass index does not reduce survival after esophagectomy for cancerMarcovalerio Melis, Jill M Weber, James M McLoughlin, et al.
The Journal of Surgical Research|October 24, 2007
Student quality-of-life declines during third year surgical clerkshipSteven B Goldin, Monika M Wahi, Osman S Farooq, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
The American Surgeon|October 16, 2004
Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapyS T Kelley, M Bloomston, F Serafini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pumpK V Shepard, B Levin, R C Karl, et al.
The Journal of Surgical Research|February 10, 2009
Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancerMarcovalerio Melis, James M McLoughlin, E Michelle Dean, et al.
The Journal of Surgical Research|August 25, 2007
Perspectives of third-year medical students toward their surgical clerkship and a surgical careerSteven B Goldin, Monika M Wahi, Lucas R Wiegand, et al.
Journal of the American College of Surgeons|May 13, 2008
Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer?James M McLoughlin, Marcovalerio Melis, Erin M Siegel, et al.
Annals of Surgical Oncology|November 3, 2011
Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomyGeorge W Dittrick, Jill M Weber, Ravi Shridhar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1993
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304E J Anaissie, D P Kontoyiannis, S Vartivarian, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 6, 2016
Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care centerAhmed I Salem, Matthew R Thau, Tobin J Strom, et al.
Annals of Surgical Oncology|September 25, 2010
An elevated body mass index does not reduce survival after esophagectomy for cancerMarcovalerio Melis, Jill M Weber, James M McLoughlin, et al.
The Journal of Surgical Research|October 24, 2007
Student quality-of-life declines during third year surgical clerkshipSteven B Goldin, Monika M Wahi, Osman S Farooq, et al.
Pageof 14